Literature DB >> 19205591

Thyroid cancer: possible role of telemedicine.

G Gibelli1, B Gibelli, F Nani.   

Abstract

Telemedicine is extremely useful when distance could hinder diagnostic procedures, disease management, or when severe side-effects may occur in patients not within easy reach of medical care and requiring prompt action and specific therapies. Telemedicine has been successfully adopted in the management of chronic patients, particularly in those with cardiologic or oncologic diseases. In the treatment of differentiated thyroid cancer, requiring long-term check-ups and visits as well as administration of high doses of levothyroxine (TSH - thyroid-stimulating hormone - suppression), also in elderly patients, telemedicine seems particularly indicated. Moreover, these distant monitoring techniques could not only reduce long-term management costs but also considerably decrease cardiovascular risks associated with these patients. The present review aims to provide some general information on telemedicine and its possible fields of action with regard to distant monitoring of patients with differentiated thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19205591      PMCID: PMC2689541     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  39 in total

1.  Baby CareLink: using the internet and telemedicine to improve care for high-risk infants.

Authors:  J E Gray; C Safran; R B Davis; G Pompilio-Weitzner; J E Stewart; L Zaccagnini; D Pursley
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Is a more active attitude warranted in patients with subclinical thyrotoxicosis?

Authors:  A Tenerz; R Forberg; R Jansson
Journal:  J Intern Med       Date:  1990-09       Impact factor: 8.989

3.  The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results.

Authors:  Kevin G Billingsley; David L Schwartz; Susan Lentz; Eric Vallières; R Bruce Montgomery; William Schubach; David Penson; Bevan Yueh; Howard Chansky; Claudia Zink; Darla Parayno; Gordon Starkebaum
Journal:  Telemed J E Health       Date:  2002       Impact factor: 3.536

4.  Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.

Authors:  B Biondi; S Fazio; C Carella; D Sabatini; G Amato; A Cittadini; A Bellastella; G Lombardi; L Saccà
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

5.  Is thyroid hormone suppression therapy prothrombotic?

Authors:  McDonald K Horne; Kulvinder K Singh; Kathryn G Rosenfeld; Robert Wesley; Monica C Skarulis; Paula K Merryman; Ann Cullinane; Rene Costello; Amy Patterson; Thomas Eggerman; Donna M Bernstein; Frank Pucino; Gyorgy Csako
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

6.  Blood pressure control by home monitoring: meta-analysis of randomised trials.

Authors:  Francesco P Cappuccio; Sally M Kerry; Lindsay Forbes; Anna Donald
Journal:  BMJ       Date:  2004-06-11

7.  Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction.

Authors:  Sevim Gullu; Fevzi Altuntas; Irem Dincer; Cetin Erol; Nuri Kamel
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

8.  Home telemonitoring for patients with severe respiratory illness: the Italian experience.

Authors:  Carmela Maiolo; Ehab I Mohamed; Cesare M Fiorani; Antonino De Lorenzo
Journal:  J Telemed Telecare       Date:  2003       Impact factor: 6.184

9.  Virtual multidisciplinary teams for cancer care.

Authors:  A T Axford; C Askill; A J Jones
Journal:  J Telemed Telecare       Date:  2002       Impact factor: 6.184

10.  Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.

Authors:  José I Botella-Carretero; Manuel Gómez-Bueno; Vivencio Barrios; Carmen Caballero; Rafael García-Robles; José Sancho; Héctor F Escobar-Morreale
Journal:  Endocr Relat Cancer       Date:  2004-06       Impact factor: 5.678

View more
  5 in total

1.  A telemedicine application to schedule temperature in an in vivo sensor network for cancer treatment.

Authors:  Rossi Kamal; Choong Seon Hong; Seok-Geun Lee
Journal:  Telemed J E Health       Date:  2012-12       Impact factor: 3.536

2.  Enhanced 911/global position system wizard: a telemedicine application for the prevention of severe hypoglycemia--monitor, alert, and locate.

Authors:  Eyal Dassau; Lois Jovanovic; Francis J Doyle; Howard C Zisser
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3.  Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.

Authors:  Alannah Smrke; Eugenie Younger; Roger Wilson; Olga Husson; Sheima Farag; Eve Merry; Aislinn Macklin-Doherty; Elena Cojocaru; Amani Arthur; Charlotte Benson; Aisha B Miah; Shane Zaidi; Spyridon Gennatas; Robin L Jones
Journal:  JCO Glob Oncol       Date:  2020-07

4.  Approach to the Patient With Thyrotoxicosis Using Telemedicine.

Authors:  Michelle L Griffith; Lindsay A Bischoff; Howard B A Baum
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

Review 5.  Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions.

Authors:  Molly O Regelmann; Rushika Conroy; Evgenia Gourgari; Anshu Gupta; Ines Guttmann-Bauman; Ryan Heksch; Manmohan K Kamboj; Sowmya Krishnan; Amit Lahoti; Kristal Matlock
Journal:  Horm Res Paediatr       Date:  2021-01-22       Impact factor: 2.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.